2000, Number 5
PDF size: 124.35 Kb.
ABSTRACTThe disorders mucocutaneous were studied in a population of HIV infected children, with or without full-blown AIDS, and were compared with a population of HIV seroreverted children. The mucocutaneous manifestations were found in 24 (80%) of the children infected and in 6 (20%) of the seroreverted children (p ‹ 0.001). The prevalence of these manifestations in the immunologic categories: without suppression, moderate suppression and severe suppression, were found in 10%, 40%, and 80%, respectively. In patients within the immunologic categories moderate and severe suppression, were significantly more common than in that the patients without suppression (p ‹ 0.001). The most common finding was the oral candidiasis (41.6%). Herpes simplex, vasculitis, reactions to drugs, and nutritional deficiencies were found in 16.7%, 16.7%, 16.7%, and 12.5% of patients respectively. The majority of these cutaneous disorders have an infectious etiology and their frequency is related to the degree of deterioration of the immune system. Some diseases commonly observed in adults are rare in children; neoplasms are an exception.
Dirección General de Epidemiología Notificación inmediata de casos de SIDA última actualización 11/01/00, por CONASIDA http//www.Gob.mx./conasida/estadis/1999.
Ash S, Hewitt C. HIV-associated cutaneous disorders. Curr Opin Infect Dis 1994; 7: 195-201.
Cockerell C, Friedman-Kien A. Cutaneous signs of HIV infection. Clin Dermatol 1993; 4: 507-24.
Coopman S, Johnson R, Platt R et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670-74.
Zuckerman G, Metrou M, Bernstein L et al. Neurologic disorders and dermatologic manifestations in HIV infected children. Pediati- Emerg Care 1991; 7: 99-105.
Centers for Disease Control. Revision 1994 after Classification System for Human immunodeficiency virus infection in children under 13 years of age. MMWR 1994; 43: RR12.
Lim W, Sadick N, Gupta A et al. Skin diseases in children with HIV infection and their association with degree of immunosupression. Int J Dermatol 1990; 29: 24-30.
Prose N. Guidelines for treatment of skin disease in children with HIV infection. J Pediatr 1991; 119: S57-S58.
Prose N. Skin problems. In: Pizzo P, Wilfert C, eds. Pediatric AIDS. Baltimore: Williams & Williams 1993: 535-46.
Friedman-Kien A, Harte J. American Academy of Dermatology symposium on AIDS. J Am Acad Dermatol 1990; 25: 1086-91.
Nigro G, Luzi G, Castelli G et al. Parvovirus infection in children with AIDS: high prevalence of B-19-specific immunoglobulin M and G antibodies. AIDS 1992; 6: 677-85.
Grossman M. Chronic hyperkeratotic herpes zoster and human immunodeficiency virus infection. J Am Acad Dermatol 1993; 28: 306-8.
Leibovitz E, Kaul A, Rigaud M et al. Chronic varicella zoster in a child infected with human immunodeficiency virus: case report and review of the literature. Cutis 1992; 49: 27-31.
Prose N. HIV infection in children. J Am Acad Dermatol 1990; 22: 1223-31.
Orlow S, Cooper D, Petra S et al. AIDS-associated Kaposi’s sarcoma in Romanian children. J Am Acad Dermatol 1993; 28: 449-53.
Straka BF, Whitaker DL, Morrison SH et al. Cutaneous manifestations of the acquired immunodeficiency syndrome in children. J Am Acad Dermatol 1988; 18: 1089-02.
Guess HA, Broughton DD, Melton LJ et al. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 1985; 76: 512-17.
Baba K, Yabuuchi H, Takahashi M et al. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study. J Pediatr 1986; 108: 372-7.
Pierre Y, Foldes C, Laurian Y. Erythema dyschromicum pertains following human immunodeficieney virus seroconversion in a child with hemophilia B. Arch Dermatol 1988; 124: 1013-14.
Zalla MJ, Daniel Su WP, Fransway AF. Dermatologic manifestations of human immunodeficiency virus infection. Mayo Clin Proc 1992; 67: 1089-1108.